From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis. [PDF]
Schnoy E +3 more
europepmc +1 more source
El objetivo del estudio está dirigida al tratamiento de la enfermedad inflamatoria intestinal (colitis ulcerosa y la enfermedad de Crohn) con agentes anti-TNF-alfa como el infliximab y adalimumab y como estos actúan, reduciendo la inflamación de las ...
Anthony Leiser Sánchez Jarrín +1 more
doaj
[Endoscopic Submucosal Dissection as a Therapeutic Option for Rectal Lesions in Patients with Ulcerative Colitis]. [PDF]
Capaldi IB +8 more
europepmc +1 more source
[Tofacitinib as Rescue Therapy in a Patient with Severe Acute Ulcerative Colitis Refractory to Corticosteroids and Infliximab: A Case Report]. [PDF]
Brizhttps C, Santo AD, Cassella F.
europepmc +1 more source
Tracheal and bronchial involvement in colitis ulcerosa - a colo-bronchitic syndrome? A case report and some additional considerations. [PDF]
von Wichert P, Barth P, von Wichert G.
europepmc +1 more source
[Postoperatively developing ulcerous skin lesions with associated ulcerative colitis in a patient with status after femorocrural (P3) bypass insertion for peripheral arterial occlusion disease]. [PDF]
Barth U +4 more
europepmc +1 more source
Electronic Nicotine Delivery Systems and Clinical Outcomes in Adults With Inflammatory Bowel Disease: A Systematic Review of Emerging Evidence. [PDF]
Ahmed H +9 more
europepmc +1 more source
[Clinical activity and validation of the disability disc in inflammatory bowel disease]. [PDF]
Plomozo-Román R +7 more
europepmc +1 more source

